“No Compounding Allowed” Drugs Would Be Established Under Senate Draft Bill
Word Count: 1080 / Article # 14130426008 / Posted: April 26 2013 6:55 PM
Executive Summary
A $15,000 annual establishment fee for “compounding manufacturers” could net FDA $45 million for inspecting those compounding sites.
Subscription required here
No comments:
Post a Comment